Total Payments
$6,123
2024 Payments
$1,026
Companies
38
Transactions
343
Medicare Patients
4,316
Medicare Billing
$178,250
Payment Breakdown by Category
Food & Beverage$6,116 (99.9%)
Education$7.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,116 | 342 | 99.9% |
| Education | $7.12 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,089 | 40 | $0 (2024) |
| Novo Nordisk Inc | $759.11 | 64 | $0 (2024) |
| GlaxoSmithKline, LLC. | $690.33 | 52 | $0 (2024) |
| Allergan, Inc. | $488.79 | 27 | $0 (2020) |
| Amgen Inc. | $318.90 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $309.38 | 11 | $0 (2023) |
| Lilly USA, LLC | $289.60 | 19 | $0 (2024) |
| PFIZER INC. | $266.07 | 21 | $0 (2024) |
| Abbott Laboratories | $210.42 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $201.02 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,026 | 54 | Novo Nordisk Inc ($336.83) |
| 2023 | $1,059 | 59 | ABBVIE INC. ($277.77) |
| 2022 | $621.54 | 37 | ABBVIE INC. ($230.60) |
| 2021 | $646.88 | 23 | AbbVie Inc. ($443.57) |
| 2020 | $476.89 | 23 | Allergan, Inc. ($195.74) |
| 2019 | $729.04 | 41 | Allergan Inc. ($228.89) |
| 2018 | $677.10 | 62 | GlaxoSmithKline, LLC. ($159.80) |
| 2017 | $886.79 | 44 | Novartis Pharmaceuticals Corporation ($209.69) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.25 | General |
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 10/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: PAIN | ||||||
| 10/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $108.85 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Endocrinology | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: PAIN | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: VACCINES | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 788 | 1,099 | $88,910 | $33,720 |
| 2022 | 23 | 1,181 | 1,665 | $127,916 | $48,628 |
| 2021 | 24 | 1,132 | 1,588 | $132,111 | $52,143 |
| 2020 | 22 | 1,215 | 1,637 | $123,812 | $43,760 |
Total Patients
4,316
Total Services
5,989
Medicare Billing
$178,250
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 256 | $48,640 | $20,639 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 29 | $4,060 | $1,712 | 42.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $1,830 | $1,648 | 90.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $1,969 | $1,645 | 83.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 92 | 128 | $7,247 | $1,285 | 17.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 86 | 100 | $6,910 | $1,261 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 93 | 149 | $1,408 | $1,244 | 88.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 100 | $3,200 | $738.17 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $816.00 | $708.24 | 86.8% |
| 87084 | Screening test for pathogenic organisms with colony count | Office | 2023 | 18 | 26 | $1,170 | $689.78 | 59.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $3,013 | $481.78 | 16.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 21 | 24 | $1,680 | $395.04 | 23.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 34 | $1,787 | $323.68 | 18.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 14 | 14 | $994.42 | $264.88 | 26.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 65 | 73 | $1,095 | $156.20 | 14.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 15 | $975.00 | $132.60 | 13.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $745.81 | $126.98 | 17.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 16 | 17 | $391.00 | $96.22 | 24.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 21 | 29 | $638.00 | $87.08 | 13.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 16 | 17 | $340.00 | $86.36 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 321 | $60,990 | $26,832 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 101 | $14,140 | $5,446 | 38.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 47 | 49 | $3,647 | $3,208 | 88.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 17 | 18 | $4,015 | $2,636 | 65.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 128 | 184 | $10,418 | $1,846 | 17.7% |
About Dr. John Perry, MD
Dr. John Perry, MD is a Family Medicine healthcare provider based in Endwell, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942220223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Perry, MD has received a total of $6,123 in payments from pharmaceutical and medical device companies, with $1,026 received in 2024. These payments were reported across 343 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,116).
As a Medicare-enrolled provider, Perry has provided services to 4,316 Medicare beneficiaries, totaling 5,989 services with total Medicare billing of $178,250. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Endwell, NY
- Active Since 07/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942220223
Products in Payments
- UBRELVY (Drug) $790.05
- VRAYLAR (Drug) $492.97
- ENTRESTO (Drug) $296.26
- JARDIANCE (Drug) $273.67
- Ozempic (Drug) $246.10
- Saxenda (Drug) $174.21
- TRELEGY ELLIPTA (Drug) $161.26
- Wegovy (Drug) $154.43
- MAKO (Device) $153.75
- EVENITY (Biological) $141.44
- SHINGRIX (Biological) $136.92
- AREXVY (Drug) $128.60
- QULIPTA (Drug) $125.04
- AJOVY (Biological) $124.54
- ELIQUIS (Drug) $121.86
- Repatha (Biological) $118.76
- ANORO (Drug) $113.62
- Rybelsus (Drug) $111.76
- DUZALLO (Drug) $111.72
- TRINTELLIX (Drug) $106.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Endwell
Suchet Patel, Md, MD
Family Medicine — Payments: $237,874
Family Medicine $237,874
Duncan Sze-Tu, Md, MD
Family Medicine — Payments: $15,417
Family Medicine $15,417
Eric Lorraine, Do, DO
Family Medicine — Payments: $12,555
Family Medicine $12,555
Kimberly Desantis, Md, MD
Family Medicine — Payments: $5,032
Family Medicine $5,032
Dr. Demetrios Gasparis, M.d, M.D
Family Medicine — Payments: $3,992
Family Medicine $3,992
Jonathan Harris, Md, MD
Family Medicine — Payments: $3,776
Family Medicine $3,776